Zallen, G <br/><br/>
Postinjury suppression of human neutrophil cytokine production results from the stabilization of inhibitory kappaB.  [electronic resource] 

 -  Shock (Augusta, Ga.)  Feb 1999 
 - 77-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-2322 
<br/><br/><label>Standard No.: </label>10.1097/00024382-199902000-00001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cytokines--blood<br/>DNA-Binding Proteins--blood<br/>Humans<br/>I-kappa B Proteins<br/>In Vitro Techniques<br/>Interleukin 1 Receptor Antagonist Protein<br/>Interleukin-8--blood<br/>Lipopolysaccharides--pharmacology<br/>N-Formylmethionine Leucyl-Phenylalanine--pharmacology<br/>Neutrophils--drug effects<br/>Platelet Activating Factor--pharmacology<br/>Postoperative Complications--blood<br/>Sialoglycoproteins--blood<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Wounds, Nonpenetrating--blood<br/>Wounds, Penetrating--blood